Hos patienter med type 2- diabetes blev de farmakokinetiske forskelle mellem insulin lispro og opløselig human insulin generelt opretholdt over varierende grader
In patients with type 2 diabetes over a wide range of renal function the pharmacokinetic differences between insulin lispro and soluble human insulin were generally maintained and shown to be independent of renal function.